Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom.
about
Report of a Bite from a New Species of the Echis Genus--Echis omanensis.Third Generation Antivenomics: Pushing the Limits of the In Vitro Preclinical Assessment of Antivenoms.Medically important differences in snake venom composition are dictated by distinct postgenomic mechanismsA multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming.Venom On-a-Chip: A Fast and Efficient Method for Comparative Venomics.Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection.New approaches & technologies of venomics to meet the challenge of human envenoming by snakebites in IndiaHaemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise.Priority Actions and Progress to Substantially and Sustainably Reduce the Mortality, Morbidity and Socioeconomic Burden of Tropical Snakebite.Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.Immunological cross-reactivity and neutralisation of European viper venoms with the monospecific Vipera berus antivenom ViperaTAbAnalysis of the efficacy of Taiwanese freeze-dried neurotoxic antivenom against Naja kaouthia, Naja siamensis and Ophiophagus hannah through proteomics and animal model approaches.Production and assessment of ovine antisera for the manufacture of a veterinary adder antivenom.The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms
P2860
Q30870286-E4B59D84-285A-4F71-992B-3EBB4D9A0A94Q33744748-E921C84F-A611-4464-92C6-B835DE8CF66DQ33835073-F9140E01-F681-4DE8-8E3B-21CB1FDEBB48Q34002730-5A75F97A-7854-47C9-8B89-F080301076E6Q36384225-399E0FF0-382D-45E1-8110-2DF3FE4BF4D1Q36654562-9A659006-0E6D-4A20-AFD9-E99772E1A268Q37156635-80975B05-3849-4FC1-8FF2-AA263EB0C796Q39149214-361CCC42-D9E8-44B3-9A6D-38D0E162BBC3Q42337645-F0F6CA56-6409-4E3A-A4D3-9ED4E9EEBE18Q42680651-7C52F658-C6AF-4816-A914-BF6D1B88BA2BQ42847712-84E085D9-6A46-4E79-AA51-BBD8C35448CDQ46240361-F707FB83-8662-4C6F-8A42-22870A0EA229Q46921265-FBE47E70-051E-435D-8AF7-AC248458A7D5Q57146126-AB7BA759-63EF-454B-9763-FF7BE6C51318
P2860
Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pre-clinical assays predict pa ...... a species-specific antivenom.
@ast
Pre-clinical assays predict pa ...... a species-specific antivenom.
@en
type
label
Pre-clinical assays predict pa ...... a species-specific antivenom.
@ast
Pre-clinical assays predict pa ...... a species-specific antivenom.
@en
prefLabel
Pre-clinical assays predict pa ...... a species-specific antivenom.
@ast
Pre-clinical assays predict pa ...... a species-specific antivenom.
@en
P2093
P2860
P50
P1476
Pre-clinical assays predict pa ...... a species-specific antivenom.
@en
P2093
Abdulsalami Nasidi
Darren A N Cook
Nandul Durfa
Robert A Harrison
P2860
P356
10.1371/JOURNAL.PNTD.0000851
P407
P577
2010-10-26T00:00:00Z